Repros Therapeutics (RPRX) 2.00 $RPRX Repros Presents

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 5:18 PM

Repros Therapeutics (RPRX) 2.00 $RPRX

Repros Presents 6-Month Interim Data on Enclomiphene
Arpita Dutt - Zacks Investment Research - Tue Aug 16, 9:39AM CDT
Repros (RPRX) is developing enclomiphene for the treatment of secondary hypogonadism in overweight men wishing to restore normal testicular function
ANIP: 59.86 (-1.56), GERN: 2.75 (+0.02), RPRX: 2.00 (unch), ANIK: 47.89 (-0.05)

Repros (RPRX) Q2 Loss Narrower Y/Y, Focus on Pipeline
Arpita Dutt - Zacks Investment Research - Wed Aug 10, 6:38AM CDT
Considering that Repros (RPRX) has no approved product in its portfolio at the moment, investor focus will remain on pipeline updates and cash burn.
CBM: 43.27 (+0.10), GERN: 2.75 (+0.02), INCY: 82.02 (+1.21), RPRX: 2.00 (unch)

Repros Therapeutics Inc.(R) Reports Second Quarter 2016 Financial Results
GlobeNewswire - Tue Aug 09, 9:16AM CDT
Repros Therapeutics Inc. (Nasdaq:RPRX) today announced financial results for the second quarter ended June 30, 2016.
RPRX: 2.00 (unch)

Repros (RPRX) Q2 Earnings: What's in Store for the Stock?
Arpita Dutt - Zacks Investment Research - Thu Aug 04, 7:45AM CDT
With Repros being a development-stage company, investors will remain focused on the company's pipeline and cash burn.
IPXL: 24.03 (+0.09), INCY: 82.02 (+1.21), RPRX: 2.00 (unch), IONS: 29.46 (-0.58)

Repros Provides Update on EU Submission of Enclomiphene for the Treatment of Secondary Hypogonadism and 3 Month Interim Results for Enclomiphene Study in Obese Secondary Hypogonadal Men
GlobeNewswire - Wed Jun 01, 3:01PM CDT
-- EU submission on track with anticipated registration decision expected Fall 2017
RPRX: 2.00 (unch)

Repros Reports Positive Clinical Data for Oral Proellex(R) in Women With Severe Menstrual Bleeding Due to Uterine Fibroids
GlobeNewswire - Wed May 18, 3:01PM CDT
-- Primary endpoint of induction of amenorrhea met for the pooled oral doses compared to placebo, p=0.0004
RPRX: 2.00 (unch)

Repros Announces the Appointment of Mr. Patrick Fourteau as Chairman of the Board
GlobeNewswire - Mon May 16, 3:00PM CDT
Repros Therapeutics Inc. (Nasdaq:RPRX) today announced that it has appointed Mr. Patrick Fourteau to its Board of Directors, where he will serve as Chairman of the Board.
INSY: 14.63 (+0.27), RPRX: 2.00 (unch)

Repros (RPRX) Q1 Loss Narrower Y/Y, Pipeline in Focus
Arpita Dutt - Zacks Investment Research - Wed May 11, 8:01AM CDT
Repros' (RPRX) loss narrowed down from the year-ago period due to lower costs.
BSTC: 36.56 (-0.99), ARQL: 1.40 (unch), APRI: 0.33 (-0.01), RPRX: 2.00 (unch)

Repros Therapeutics reports 1Q loss
Automated Insights - Tue May 10, 8:19AM CDT
WOODLANDS, Texas (AP) _ Repros Therapeutics Inc. (RPRX) on Tuesday reported a loss of $4.8 million in its first quarter.
RPRX: 2.00 (unch)

Drug Stocks Earnings Preview: GERN, RPRX, ICPT, AGIO & More
Zacks Equity Research - Zacks Investment Research - Wed May 04, 10:25AM CDT
As we approach the end of this earnings season, investors will possibly heave a sigh of relief seeing that the going was not as bad as expected.
ABT: 42.09 (-0.21), BIIB: 313.59 (+7.56), CNAT: 1.84 (-0.02), AMGN: 169.77 (-0.36), RPRX: 2.00 (unch), JNJ: 119.32 (+0.24), GILD: 76.89 (-0.53), GWPH: 82.73 (+0.45), GERN: 2.75 (+0.02), AVEO: 0.90 (-0.01), ICPT: 150.74 (+3.92), AGIO: 36.35 (-0.39), NVS: 79.38 (+1.11)

Will Repros Therapeutics (RPRX) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Wed May 04, 7:56AM CDT
As of late, it has definitely been a great time to be an investor in Repros Therapeutics Inc. (RPRX).
RPRX: 2.00 (unch)

These Four Biotech Stocks Are Trading With Massive Volume Today
ACCESSWIRE - Tue Apr 19, 9:05AM CDT
NEW YORK, NY / ACCESSWIRE / April 19, 2016 / The Stock Expert is issuing a report on four stocks that are trading with heavier than usual volume. SGYP, RPRX, CPXX and HRTX are on high volume alert. Continue reading to find out why. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
CPXX: 30.24 (unch), SGYP: 4.77 (+0.01), HRTX: 17.70 (-0.63), RPRX: 2.00 (unch)

Trending Stocks: Investors Have Found Interest In These Four Nasdaq Stocks on Monday
ACCESSWIRE - Mon Apr 18, 11:35AM CDT
MIAMI, FL / ACCESSWIRE / April 18, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. RPRX, COOL, CLMT, and UNXL have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
UNXL: 1.48 (unch), COOL: 3.70 (-0.05), RPRX: 2.00 (unch), CLMT: 5.47 (-0.04)

Trending Stocks: Thursday's Top Trading Stock Investors Have Followed
ACCESSWIRE - Thu Apr 14, 11:07AM CDT
MIAMI, FL / ACCESSWIRE / April 14, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. COOL, SUNE, RPRX, and EXXI have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
EXXI: 0.13 (-0.01), COOL: 3.70 (-0.05), SUNE: 0.34 (unch), RPRX: 2.00 (unch)

4 Small Cap Stocks That Have To Be On Your Watchlist Today
ACCESSWIRE - Thu Apr 14, 7:30AM CDT
NEW YORK, NY / ACCESSWIRE / April 14, 2016 / The Stock Expert is issuing a report on four stocks that are trading with heavier than usual volume. RPRX, FELP, CLDX and FNJN are on high volume alert. We have been following RPRX and FELP all week this week. Continue reading to find out why. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
CLDX: 3.35 (-0.01), RPRX: 2.00 (unch), FNJN: 1.60 (-0.02), FELP: 4.57 (+0.17)

Repros Therapeutics (RPRX) Announces Significant Data for Proellex Phase 2 Meeting with the FDA to Jointly Discuss Plans for Phase 3
ACCESSWIRE - Wed Apr 13, 12:28PM CDT
THE WOODLANDS, TX / ACCESSWIRE / April 13, 2016 / Repros Therapeutics Inc.® (NASDAQ: RPRX) reported that vaginal administration of Proellex at doses of both 6 and 12 mg achieved significant reduction in excessive menstrual bleeding, the key symptom of uterine fibroids.
RPRX: 2.00 (unch)

Repros Reveals Positive Data on Proellex for Uterine Fibroids
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 11:30AM CDT
Repros (RPRX) reported positive data from a phase IIb study on Proellex (vaginal administration) for the treatment of women suffering from uterine fibroids.
EBS: 26.90 (+0.49), RPRX: 2.00 (unch), AMAG: 23.66 (-0.05), ANIK: 47.89 (-0.05)

These Small Cap Stocks Are Getting Big Time Attention Today
ACCESSWIRE - Wed Apr 13, 9:50AM CDT
NEW YORK, NY / ACCESSWIRE / April 13, 2016 / The Stock Expert is issuing a report on four stocks that are trading with heavier than usual volume. RPRX, FELP, EMKR and SUNE are on high volume alert. Continue reading to find out why these stocks are getting so much interest today. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
EMKR: 5.08 (+0.10), SUNE: 0.34 (unch), RPRX: 2.00 (unch), FELP: 4.57 (+0.17)

Repros Reports Positive Clinical Data for Vaginal Proellex(R) in Women With Severe Menstrual Bleeding Due to Uterine Fibroids
GlobeNewswire - Tue Apr 12, 3:01PM CDT
-- Primary endpoint of induction of amenorrhea met for both vaginal doses compared to placebo, p<0.0011
RPRX: 2.00 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ViewScan Unveils New AI Solution and Enhanced Site

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

Charter Next Generation Taps Herndon as Financial Chief

Bringing New Leadership to Charter Next Generation It's an intriguing time to be watching Charter Next Generation (CNG) as they just added a heavyweight to their executive team. Todd Herndon, a veteran with more than three decades of financial savvy, steps in as their new Chief Financial Officer. This is like a football team drafting a star quarterback right before the...

Beemo, Choreo Forge AI Partnership for Wealth Management

AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...

Saudi Arabia Unveils CEER's Flagship Electric Vehicles

CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...

TerraMaster 725 NAS Unveils AI-Era Storage Solutions

Tech Giants and Pioneers Rejoice Strap in, because TerraMaster just waved the green flag on their brand-new 725 Series Xeon Rackmount NAS, and it's high time the data storage world got a shake-up. Picture this: we're in the throes of an AI boom, and companies have data needs that gobble up yesterday's solutions with the hunger of a black hole. Well, enter TerraMaster's...

Partners International Launches CareerPath for Youth

A Fresh Start for Young Careers with CareerPath You remember the time in life when we thought just having a degree meant something? Well, the game’s changed, and now it’s a twisted jungle where young folks struggle to find their footing. Partners International, a name I’m no stranger to—known for their human capital wizardry—seems to have noticed this chaotic...

GRAI's Innovative Play with Hangout FM in Streaming

Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...

Aranscia Joins Northside Hospital in Precision Oncology

Unifying Molecular Diagnostics for Better Cancer Care In the chaos of today’s healthcare, Aranscia is aiming to rewrite the book on how we handle cancer diagnostics by teaming up with Northside Hospital Cancer Institute. Now, instead of fumbling through disconnected systems, they plan to glue the pieces together with a blend of their own and borrowed tech. This...

Matchi Debuts Protein-Packed Matcha Lattes in Cans

A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...

Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...